Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 24 ... a multi-year technology licensing agreement establishing the breakthrough noninvasive blood constituent monitoring capabilities of Masimo Rainbow SET Pulse CO-Oximetry technology ... low-perfusion SpO2, pulse rate, and perfusion index measurements--provides an additional safety net for risk factors not covered by programming safety and bar coding, such as ...
2009 NOV 28 ... Medical Technologies, a family-owned Texas company that produces The Thermal Angel Blood and IV Fluid Infusion Warmer, was named one of the area's 100 fastest-growing ... Angel can serve emergency responders, paramedics, pre-hospital practitioners and public safety responders to reach their readiness goals by helping them serve vulnerable patient ...
2009 NOV 27 ... to clean, which help reduce the risk of pathogens. Vinyl is the material of choice for blood bags and intravenous tubing. The safety of vinyl in the health care sector has been ...
2009 NOV 26 ... were found between the two groups with respect to adverse events by body system, blood pressure, or laboratory values. There was a significantly higher incidence of upper ... "This study was designed to determine the safety of a medical food, flavocoxid, a proprietary blend of free-B ring flavonoids and flavans ...
2009 NOV 23 ... average glucose control (A1C) they can achieve without increasing hypoglycemia (low blood sugar). Moreover, evidence is mounting for a variety of patients, including those with ... Personal CGM use. STAR 1 Trial2 (146 Patients, Ages 12-72): This trial evaluated the safety and efficacy of an insulin pump with Personal CGM compared to an insulin pump alone in ...
2009 NOV 23 ... days), with alternate single doses of LDX 50 mg or MAS XR 20 mg added on days 7 and 11. Blood samples were collected predose and 0 to 96 hours postdose for pharmacokinetic analysis. ... samples were collected predose and 0 to 96 hours postdose for pharmacokinetic analysis. Safety assessments included adverse events (AEs). Overall, 24 subjects were randomized; 21 ...
2009 NOV 23 ... the proximal margin was significantly longer in the TLDG group (p < 0.05). The mean blood loss was significantly less in the TLDG group (p < 0.05). The patients in the TLDG ... has several advantages over open distal gastrectomy, little has been reported about the safety and feasibility of totally laparoscopic distal gastrectomy (TLDG)." ...
2009 NOV 23 ... a 5-lipoxygenase-activating protein (FLAP) binding assay, an IC50 of 349 nM in the human blood LTB4 inhibition assay, and is efficacious in a murine ovalbumin model of ... inhibition of leukotriene synthesis in addition to having excellent pharmacokinetics and safety in rats and dogs." "The key structural features of these new compounds ...
2009 NOV 23 ... HDL-C and reduces LDL-C when administered alone or with a statin. Adverse effects on blood pressure, electrolytes, and aldosterone levels, seen with another drug in this class, ... is a randomized, double-blind, placebo-controlled trial to assess the efficacy and safety profile of anacetrapib in patients with coronary heart disease (CHD) or CHID risk ...
2009 NOV 24 ... color word test, Rey-Osterrieth Complex Figure, and Auditory Consonant Trigram tests. AN blood levels and air sampling data in the form of both personal and area samples were ... the five outcomes," wrote R.M. Park and colleagues, National Institute for Occupational Safety and Health. The researchers concluded: "A risk assessment performed for ...
2009 NOV 23 ... to observe any changes that accompanied accrued experience, and to measure and correlate blood loss and temporal efficiency with anesthesia-induced relative hypotension. ... this recent study, researchers in the United States conducted a study "To quantify the safety and efficiency of Postgraduate-Year II head-and-neck-surgery residents who perform ...
2009 NOV 23 ... trial in type 2 diabetics designed to examine the effects of intensive reduction of blood pressure, aggressive vs standard goals (< 115/75 mm Hg vs < 130/80 mm Hg), and ... and more aggressive systolic blood pressure reduction can be achieved with excellent safety and good tolerability in patients with type 2 diabetes mellitus." Weir and ...
2009 NOV 23 ... patients reported contact with a sick cat and 47 (94%) presented comorbidities (high blood pressure: 64.0%; diabetes mellitus: 30.0%; dyslipidemia: 16.7%; depression: 10.0%; ... is limited by its interaction with other drugs. To evaluate the effectiveness and safety of 250 mg terbinafine for the treatment of cutaneous sporotrichosis in patients in whom ...
2009 NOV 26 ... in these measures. No adverse reactions, abnormal symptoms, or changes in body weight, blood pressure, pulse, visual acuity, urine, stool, or blood biochemistry were seen in either ... the systematic effects of L. barbarum on immune function, general well-being, and safety, we tested the effects of a standardized L. barbarum fruit juice (GoChi ®, FreeLife ...
2009 NOV 26 ... practice surgeons were studied. The average surgical time (164 minutes) and estimated blood loss (858 mL) were more than double, and the major complication rate (9%) was 6 times ... "There are no data regarding the efficacy and safety of minimally invasive hip arthroplasty technique performed by community practice ...
2009 NOV 24 ... 20th, 2009. Beverly Hills based WALKING SHADOWS has announced the theatrical release of BLOOD EQUITY, Super Bowl Champ Roman Phifer's controversial film about NFL Player Injuries: ... listings or visit www.laemmle.com. In recent days, NFL injuries and the "safety" epidemic have caught the attention of Congress, the media, and the nation at large, ...
2009 NOV 23 ... that catheter-based renal denervation yields significant and sustained reductions in blood pressure in patients with multidrug-resistant hypertension. The Symplicity HTN-1 study, ... System in the SFA William A. Gray, MD, presented interim 6-month clinical results on the safety and efficacy of the FlexStent femoropopliteal self-expanding stent system (Flexible ...
2009 NOV 23 ... image-guided drug delivery with specially designed catheters to dissolve dangerous blood clots in the lungs--saves lives and should be considered a first-line treatment option ... for acute pulmonary embolism saves lives, and we need to raise awareness about its safety and effectiveness not only among the general public but also within the medical ...
2009 NOV 23 ... Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced William H. Cork has joined ...
